Literature DB >> 22312047

Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Peter Parham1, Paul J Norman, Laurent Abi-Rached, Lisbeth A Guethlein.   

Abstract

In placental mammals, natural killer (NK) cells are a population of lymphocytes that make unique contributions to immune defence and reproduction, functions essential for survival of individuals, populations and species. Modulating these functions are conserved and variable NK-cell receptors that recognize epitopes of major histocompatibility complex (MHC) class I molecules. In humans, for example, recognition of human leucocyte antigen (HLA)-E by the CD94:NKG2A receptor is conserved, whereas recognition of HLA-A, B and C by the killer cell immunoglobulin-like receptors (KIRs) is diversified. Competing demands of the immune and reproductive systems, and of T-cell and NK-cell immunity-combined with the segregation on different chromosomes of variable NK-cell receptors and their MHC class I ligands-drive an unusually rapid evolution that has resulted in unprecedented levels of species specificity, as first appreciated from comparison of mice and humans. Counterparts to human KIR are present only in simian primates. Observed in these species is the coevolution of KIR and the four MHC class I epitopes to which human KIR recognition is restricted. Unique to hominids is the emergence of the MHC-C locus as a supplier of specialized and superior ligands for KIR. This evolutionary trend is most highly elaborated in the chimpanzee. Unique to the human KIR locus are two groups of KIR haplotypes that are present in all human populations and subject to balancing selection. Group A KIR haplotypes resemble chimpanzee KIR haplotypes and are enriched for genes encoding KIR that bind HLA class I, whereas group B KIR haplotypes are enriched for genes encoding receptors with diminished capacity to bind HLA class I. Correlating with their balance in human populations, B haplotypes favour reproductive success, whereas A haplotypes favour successful immune defence. Evolution of the B KIR haplotypes is thus unique to the human species.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22312047      PMCID: PMC3267113          DOI: 10.1098/rstb.2011.0266

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  90 in total

1.  Self and viral peptides can initiate lysis by autologous natural killer cells.

Authors:  O Mandelboim; S B Wilson; M Valés-Gómez; H T Reyburn; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

2.  The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.

Authors:  V Braud; E Y Jones; A McMichael
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

Review 3.  Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations.

Authors:  Kerry S Campbell; Amanda K Purdy
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

4.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

5.  Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates.

Authors:  Jennifer G Sambrook; Arman Bashirova; Sophie Palmer; Sarah Sims; John Trowsdale; Laurent Abi-Rached; Peter Parham; Mary Carrington; Stephan Beck
Journal:  Genome Res       Date:  2005-01       Impact factor: 9.043

6.  Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products.

Authors:  Simona Sivori; Michela Falco; Lorenzo Moretta; Alessandro Moretta
Journal:  Trends Immunol       Date:  2010-07-12       Impact factor: 16.687

7.  Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors.

Authors:  Raja Rajalingam; Peter Parham; Laurent Abi-Rached
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

8.  Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes.

Authors:  Achim K Moesta; Laurent Abi-Rached; Paul J Norman; Peter Parham
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

9.  Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.

Authors:  Deepti Sharma; Karine Bastard; Lisbeth A Guethlein; Paul J Norman; Nobuyo Yawata; Makoto Yawata; Marcelo Pando; Hathairat Thananchai; Tao Dong; Sarah Rowland-Jones; Frances M Brodsky; Peter Parham
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

10.  Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule.

Authors:  C J VandenBussche; T J Mulrooney; W R Frazier; S Dakshanamurthy; C K Hurley
Journal:  Genes Immun       Date:  2008-11-13       Impact factor: 2.676

View more
  82 in total

1.  Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.

Authors:  Hugo G Hilton; Luca Vago; Anastazia M Older Aguilar; Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; Katharina Fleischhauer; Peter Parham
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

2.  Two Orangutan Species Have Evolved Different KIR Alleles and Haplotypes.

Authors:  Lisbeth A Guethlein; Paul J Norman; Corinne M C Heijmans; Natasja G de Groot; Hugo G Hilton; Farbod Babrzadeh; Laurent Abi-Rached; Ronald E Bontrop; Peter Parham
Journal:  J Immunol       Date:  2017-03-06       Impact factor: 5.422

3.  Diverse approaches to analysing the history of human and pathogen evolution: how to tell the story of the past 70 000 years.

Authors:  D M Altmann; F Balloux; R J Boyton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

4.  Deleterious impact of feto-maternal MHC compatibility on the success of pregnancy in a macaque model.

Authors:  Alice Aarnink; Edward T Mee; Nicolas Savy; Nicolas Congy-Jolivet; Nicola J Rose; Antoine Blancher
Journal:  Immunogenetics       Date:  2013-12-28       Impact factor: 2.846

5.  Associations between the presence of specific antibodies to the West Nile Virus infection and candidate genes in Romanian horses from the Danube delta.

Authors:  K Stejskalova; E Janova; C Horecky; E Horecka; P Vaclavek; Z Hubalek; K Relling; M Cvanova; G D'Amico; A D Mihalca; D Modry; A Knoll; P Horin
Journal:  Mol Biol Rep       Date:  2019-06-07       Impact factor: 2.316

Review 6.  The role of invasive trophoblast in implantation and placentation of primates.

Authors:  Anthony M Carter; Allen C Enders; Robert Pijnenborg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-03-05       Impact factor: 6.237

7.  Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma.

Authors:  Anupam Dutta; Nabajyoti Saikia; Jyotirmoy Phookan; Munindra Narayan Baruah; Shashi Baruah
Journal:  Immunogenetics       Date:  2014-05-13       Impact factor: 2.846

8.  Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.

Authors:  Rafijul Bari; Piya Rujkijyanont; Erin Sullivan; Guolian Kang; Victoria Turner; Kwan Gan; Wing Leung
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

9.  Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11.

Authors:  Jingxian Liu; Ziwei Xiao; Hui Ling Ko; Meixin Shen; Ee Chee Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 10.  Exploring the NK cell platform for cancer immunotherapy.

Authors:  Jacob A Myers; Jeffrey S Miller
Journal:  Nat Rev Clin Oncol       Date:  2020-09-15       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.